6LC8
 
 | | Crystal structure of AmpC Ent385 complex form with avibactam | | Descriptor: | (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide, 1,4-DIETHYLENE DIOXIDE, Beta-lactamase, ... | | Authors: | Kawai, A, Doi, Y. | | Deposit date: | 2019-11-18 | | Release date: | 2020-04-22 | | Last modified: | 2022-03-23 | | Method: | X-RAY DIFFRACTION (1.6 Å) | | Cite: | Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol inEnterobacter cloacaeDue to AmpC R2 Loop Deletion.
Antimicrob.Agents Chemother., 64, 2020
|
|
6LC9
 | | Crystal structure of AmpC Ent385 complex form with ceftazidime | | Descriptor: | 1,4-DIETHYLENE DIOXIDE, ACYLATED CEFTAZIDIME, Beta-lactamase, ... | | Authors: | Kawai, A, Doi, Y. | | Deposit date: | 2019-11-18 | | Release date: | 2020-04-22 | | Last modified: | 2022-03-23 | | Method: | X-RAY DIFFRACTION (1.65 Å) | | Cite: | Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol inEnterobacter cloacaeDue to AmpC R2 Loop Deletion.
Antimicrob.Agents Chemother., 64, 2020
|
|
6LC7
 | | Crystal structure of AmpC Ent385 free form | | Descriptor: | 1,4-DIETHYLENE DIOXIDE, Beta-lactamase, GLYCEROL, ... | | Authors: | Kawai, A, Doi, Y. | | Deposit date: | 2019-11-18 | | Release date: | 2020-04-22 | | Last modified: | 2023-11-22 | | Method: | X-RAY DIFFRACTION (1.4 Å) | | Cite: | Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol inEnterobacter cloacaeDue to AmpC R2 Loop Deletion.
Antimicrob.Agents Chemother., 64, 2020
|
|
